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Case Report
Critical illness myopathy
Salima Moez Meherali, Yasmin Parpio, Tazeen Saeed Ali
School of Nursing, Department of Community Health Sciences, The Aga Khan University, Karachi.
Abstract
Critical illness myopathy (CIM) is a syndrome of
widespread muscle weakness and neurological dysfunction
which can develop in critically ill patients receiving intensive
care. CIM are often distinguished largely on the basis of
specialized electrophysiologic testing or muscle and nerve
biopsy and its causes are unknown, though they are thought to
be a possible neurological manifestation of systemic
inflammatory response syndrome usually developing in
patients after a brief period of stay in the Intensive Care Unit
(ICU). This case report aims to analyze the Clinical feature,
diagnosis and treatment of CIM of 60 years old male case with
Chronic Obstructive Lung disease (COPD) admitted to the
intensive care. Health professionals working at critical care
unit should be aware that any ICU patient may develop CIM. 
Introduction
Until recently, in most of the critical care units,
survival to hospital discharge was the primary outcome.
However, the body of knowledge is now being developed
to focus more on health-related quality of life. It is widely
recognized that patients admitted to the intensive care unit
often develop subsequent difficulties with neuromuscular
function,1 whereby Critical illness Myopathy (CIM) is the
most common one. In CIM, myopathies developed to
critical patients even after a brief period of stay in the
intensive care unit.1 It occurs in 25-63% of patients who
have been mechanically ventilated for > one week. Recent
studies have revealed that myopathies are in fact more
prevalent than neuropathies and early recognition and
interventions would have better patient outcome.2
Case Report
A 60 year old male with past history of COPD
presented in Emergency Department (ED) with tachypnoea,
cynosia, hypoxaemia, hypercapnia and acidesia. The
physicians in the ED diagnosed status asthmaticus. Patient
was intubated, and started on intravenous
methylprednisolone, intravenous theophylline, and aerosol
bronchodilators. A chest radiograph showed a right perihilar
infiltrate suggestive of pneumonia. The patient was admitted
to ICU. He received multiple antibiotics along with
lorazepam and midazolam intravenously for sedation and was
kept on sliding scale of insulin. No neuromuscular blocking
agents were used during the hospital course.
The hospital course was complicated by the
development of ARDS and later tension pneumothorax
requiring a chest tube. During this time period, the patient's
mental status changed indicating mutlple conditions like:
hypoxia, hypercapnia, and sedating drugs and hence, his
length of stay in ICU increased. Later, patient's mental status
gradually improved, ARDS got resolved and gradually lung
compliance improved. After spending a month in ICU, he
was extubated. At that time, it was noted that patient has
marked muscle wasting and diffuse weakness of his
extremities more distally than proximally. His muscle
strength was graded 2 to 3 on a scale of 5 proximally and 0 to
2 distally. His sensory systems and reflexes were normal. The
muscles of the neck and respiratory system were not weak,
and there were no other significant findings on neurological
assessment. 
Discussion
This case was subjected to a number of differential
diagnoses. The most likely diagnoses at that time was
Electrolyte disturbance (e.g. hypokalaemia, hypercalcaemia,
hypermagnesaemia, hypophosphataemia) and other
metabolic derangements. Guillain-Barré syndrome was
unlikely, even though the patient had symmetric weakness,
his reflexes were normal and he did not have sensory
disturbances, autonomic dysfunction, or involvement of the
extraocular or facial muscles. Stroke typically presents as an
acute focal neurologic deficit with an upper motor neuron
pattern of weakness. This patient had generalized weakness
of the lower motor neuron type without significant cerebral or
brain stem dysfunction. Hopkins syndrome, sometimes called
acute post-asthmatic amyotrophy, is an acute attack of muscle
weakness that arises in a small number of patients with
asthma, not necessarily occurring in ventilated patient.2
Critical illness myopathy (CIM) can present with
acute-onset weakness in the critical care setting and has been
reported in patients with COPD, status asthamaticus, ARDS
and sepsis who have received steroids in high doses and non-
depolarizing neuromuscular blocking agents.3
To confirm the diagnosis of CIM and differentiate it
from other illnesses, electromyogram (EMG) and nerve
conduction (NC) were done which showed reduction of
amplitude and duration of muscle compound action potentials
and ± decreased amplitude of sensory nerve action potentials
which is common in both CIM and critical illness
polyneuropathy (CIP).4
It is not easy to classify as strictly CIP or CIM.
Therefore, differentiating between both disorders, the
needle EMG was done which shows fibrillation potentials
and positive sharp waves of low amplitude, particularly in
distal muscles. Creatine phosphokinase (CPK) levels were
relatively normal (170units/L), consistent with a myopathy
Finally, muscle biopsy was done which demonstrated
myopathy as there was myosin loss. The physical
examination also revealed that muscle weakness and
wasting was more prominent in the proximal than the distal
extremities. Initially, reflexes were present but disappeared
during the course of the diseases. The presentation of this
patient was consistent with critical illness myopathy.
This case illustrates a common problem in critical
care setting that is usually unrecognized. The term critical
illness myopathy describes a group of myopathies, which
commonly occur in critically ill patients.2,5 The risk factors
of CIM are sepsis and systemic inflammatory response
syndrome (SIRS) which disturbs the microcirculation
throughout the body.3 The release of inflammatory
mediators during sepsis allows the passage of toxic
substances (e.g.neuromuscular-blocking agents, and
corticosteroids.3 Multi-organ dysfunction syndrome is also
identified as a significant risk factor of CIM,6,7 but its
mechanism remains unknown.6 The use of neuromuscular-
blocking agents such as vecuronium has been associated
with CIM development.2 Furthermore the use of
Aminoglycosides have been cited as a risk factor,1,2 but not
been shown as an independent risk factor,2 but may
adversely affect "axons" in the hyper permeable state along
with sepsis.2
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Today it is agreed that the SIRS is responsible for the
release of a number of proinflammatory cytokines and other
metabolites into the blood accounts for the muscle organ
failure of CIM that is similar to other organ failures seen in
patients with sepsis.2 External factors trigger the onset of
CIM are high-dose steroids, administered to critically ill
patients with respiratory distress syndrome or asthma muscle
protein depletion is much more rapid and extensive in the
critically ill patients coupled with inappropriate nutritional
support lead to the development of myopathies.6
The clinical features of CIM are quite nonspecific, the
most important of which are generalized muscle weakness
and atrophy more distally than proximally,6 which are more
severe than expected from immobilization alone, and delayed
weaning from the respirator7 as occurred in the patient
presented above. Both factors inevitably result in a
prolongation not only of ICU treatment. In addition, CIM
causes secondary complications such as pneumonia, deep
vein thrombosis and lung embolism.7
The diagnosis of CIM is challenging and it is usually
diagnosed during the process of delayed weaning from
mechanical ventilation and progressive muscle weakness.5
The other diagnostic tests which would be useful in the
patient are Serum electrolytes, cerebrospinal fluid analysis,
imaging studies of the spinal cord, electro diagnostic
examination and muscle and nerve biopsy. 
In treatment clinicians should minimize the use of
steroids and neuromuscular blocking agents, particularly
vecuronium.7 Earlier therapeutic intervention in physical
therapy may prove to be of benefit, to prevent the disuse
atrophy.6 Lack of physical activity, in fact, may amplify the
catabolic effects of cortisol on muscle protein degradation.3,8
Nutritional and supplemental therapies include protein and
amino acid supplementation, antioxidant therapy, and
hormonal therapy are also found helpful in treating CIM.8
Novak and colleagues identified that glutamine
supplementation were associated with decreased mortality;
shorter hospital length of stay and a lower incidence of ICU
acquired myopathies.9
Further, testosterone hormonal therapies are also
beneficial in the treatment of myopathies in male ICU
patients.10 The testosterone derivative oxandrolone may
improve muscle strength in the case of muscular dystrophy.10
Finally, tightly controlling glucose levels with I/V, insulin
infusions are also recognized useful in the treatment and
prevention of CIM.11
Critical-illness myopathy is fairly neglected in critical
care setting. Standardized screening for weakness is
uncommon, and persistent weakness as a sequela of critical
illness is usually not recognized by physicians in the ICU.
Mostly patients develop this condition after they are moving
out from ICU, either in the hospital or as an outpatient which
may lead to the development of complications and affect the
quality of life of the survivor. 
The management should be aimed to optimize the
care available for CIM patients in the short- and long-term by
having multidisciplinary approach.
Critical care nurse and physicians should assess the
patients who are on high doses of steroids and
neuromuscular blocking agents in every shift to minimize
the steroid doses according to patients' condition. In
addition, balanced nutritional requirement adjusted with
protein intake and range of motion exercises is essential
for the prevention of muscle atrophy. Health professionals
should be aware about CIM, to provide interventions to
prevent early detect and manage for the quality of life of
critically ill patients.
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